BACK TO EVENTS
Global Markets 2 Oct 2026, 2:26 pm IST
Novartis (NVS) Secures $575M Licensing Deal with Abogen Biosciences for Innovative mRNA Therapy
On October 02, 2026, Novartis AG (NYSE: NVS) announced a significant licensing and option agreement with Abogen Biosciences, which includes an upfront payment o
gurufocus.comGenerating AI analysis…
Claude Sonnet is analyzing this event. This page will refresh automatically in a few seconds.